Drug & Medication Database
Browse 18,617 FDA-approved medications with detailed information about uses, dosage, side effects, and interactions.
Trametinib Acetic Acid
trametinib acetic acid
Dosage form: POWDER. Active ingredients: TRAMETINIB (50 kg/50kg). Category: BULK INGREDIENT.
Trametinib Dimethyl Sulfoxide
trametinib dimethyl sulfoxide
Dosage form: POWDER. Active ingredients: TRAMETINIB DIMETHYL SULFOXIDE (1 kg/kg). Category: BULK INGREDIENT.
Trametinib Dimethylsulfoxide (form-m)
trametinib dimethylsulfoxide (form-m)
Dosage form: POWDER. Active ingredients: TRAMETINIB DIMETHYL SULFOXIDE (1 kg/kg). Category: BULK INGREDIENT.
Tramiprosate
tramiprosate
Dosage form: POWDER. Active ingredients: TRAMIPROSATE (1 kg/kg). Category: BULK INGREDIENT.
Trandolapril
trandolapril
DESCRIPTION Trandolapril is the ethyl ester prodrug of a nonsulfhydryl angiotensin converting enzyme (ACE) inhibitor, trandolaprilat. Trandolapril is chemically described as (2S,3aR,7aS)-1-[(S)-N-[(S)-1-Carboxy-3-phenylpropyl] alanyl] hexahydro-2-indolinecarboxylic acid, 1-ethyl ester.
Brands: Trandolapril
Trandolapril And Verapamil Hydrochloride
trandolapril and verapamil hydrochloride
DESCRIPTION Trandolapril and verapamil hydrochloride extended-release tablets combine a slow release formulation of a calcium channel blocker, verapamil hydrochloride, USP, and an immediate release formulation of an angiotensin converting enzyme inhibitor, trandolapril, USP. Verapamil Component Verapamil hydrochloride, USP is chemically described as benzeneacetonitrile, α [3-[[2-(3,4-dimethoxyphenyl) -ethyl] methylamino] propyl] -3,4-dimethoxy-α -(1-methylethyl)-, monohydrochloride, (±).
Brands: Trandolapril And Verapamil Hydrochloride
Trandolapril Tablets
trandolapril tablets
DESCRIPTION Trandolapril is the ethyl ester prodrug of a nonsulfhydryl angiotensin converting enzyme (ACE) inhibitor, trandolaprilat. Trandolapril is chemically described as (2S, 3aR, 7aS)-1-[(S)-N-[(S)-1-Carboxy-3-phenylpropyl]alanyl] hexahydro-2-indolinecarboxylic acid, 1- ethyl ester. Its empirical formula is C 24 H 34 N 2 O 5 and its structural formula is: M.W.
Brands: Trandolapril
Tranexamic Acid
tranexamic acid
Tranexamic acid tablets are oral antifibrinolytic agents for the treatment of cyclic heavy menstrual bleeding in females of reproductive potential.
Brands: Tranexamic Acid
Tranilast
tranilast
Dosage form: POWDER. Active ingredients: TRANILAST (10 g/10g). Category: BULK INGREDIENT.
Transforming Growth Factor Beta 1
transforming growth factor beta 1
PURPOSE Anti-inflammatory
Brands: Guna-tgf Beta 1
Transparent Gel Sunscreen Spf50
transparent gel sunscreen spf50
Sunscreen
Brands: Transparent Gel Sunscreen Spf50, Flirt With The Sun
Tranylcypromine
tranylcypromine
11 DESCRIPTION Tranylcypromine sulfate, the active ingredient of Tranylcypromine Tablets, USP, is a non-hydrazine MAOI. The chemical name is (±)- trans -2-phenylcyclopropylamine sulfate (2:1). The molecular formula is (C 9 H 11 N) 2 ∙H 2 SO 4 and its molecular weight is 364.46. The structural formula is: Tranylcypromine film-coated tablets are intended for oral administration.
Brands: Tranylcypromine
Tranylcypromine Sulfate
tranylcypromine sulfate
11 DESCRIPTION Tranylcypromine sulfate, the active ingredient of tranylcypromine sulfate tablets, is a non-hydrazine MAOI. The chemical name is (±)‑ trans ‑2‑phenylcyclopropylamine sulfate (2:1). The molecular formula is (C 9 H 11 N) 2 •H 2 SO 4 and its molecular weight is 364.46. The structural formula is: Tranylcypromine sulfate tablets film-coated tablets are intended for oral administration.
Brands: Tranylcypromine Sulfate
Trastuzumab
trastuzumab
11 DESCRIPTION Trastuzumab-pkrb is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Trastuzumab-pkrb is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary) culture. HERZUMA (trastuzumab-pkrb) for injection is a sterile, white to pale yellow, preservative-free lyophilized powder with a cake-like appearance, for intravenous administration.
Brands: Herzuma
Trastuzumab And Hyaluronidase-oysk
trastuzumab and hyaluronidase-oysk
11 DESCRIPTION HERCEPTIN HYLECTA is a combination of trastuzumab and hyaluronidase. Trastuzumab is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Trastuzumab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary) culture. Trastuzumab has a molecular weight of approximately 148 kDa.
Brands: Herceptin Hylecta
Trastuzumab Deruxtecan
trastuzumab deruxtecan
Dosage form: POWDER, FOR SOLUTION. Active ingredients: TRASTUZUMAB DERUXTECAN (22 g/22g). Category: BULK INGREDIENT.
Trastuzumab Emtansine
trastuzumab emtansine
Dosage form: LIQUID. Active ingredients: TRASTUZUMAB EMTANSINE (20 mg/mL). Category: DRUG FOR FURTHER PROCESSING.
Trastuzumab-anns
trastuzumab-anns
11 DESCRIPTION Trastuzumab-anns is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Trastuzumab-anns is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary) culture containing the antibiotic geneticin. Geneticin is not detectable in the final product.
Brands: Kanjinti
Trastuzumab-dkst
trastuzumab-dkst
11 DESCRIPTION Trastuzumab-dkst is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Trastuzumab-dkst is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary) culture.
Brands: Ogivri
Trastuzumab-qyyp
trastuzumab-qyyp
11 DESCRIPTION Trastuzumab-qyyp is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Trastuzumab-qyyp is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary) culture. TRAZIMERA (trastuzumab-qyyp) for injection is a sterile, white, preservative-free lyophilized powder with a cake-like appearance, for intravenous administration.
Brands: Trazimera
Trastuzumab-strf
trastuzumab-strf
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION. Route: INTRAVENOUS. Active ingredients: TRASTUZUMAB-STRF (420 mg/20mL). Category: BLA.
Brands: Hercessi
Travel Immunization Detox
travel immunization detox
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Brands: Travel Immunization Detox 6033
Travel Lite Hand Sanitizing Gel
travel lite hand sanitizing gel
Purpose Antiseptic
Brands: Travel Lite Hand Sanitizing Gel
Travel Sickness Drops
travel sickness drops
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Brands: Travel Sickness Drops 2075
Travoprost
travoprost
11 DESCRIPTION Travoprost is a synthetic prostaglandin F analogue. Its chemical name is [1 R -[1α( Z ),2β(1 E ,3 R *),3α,5α]]-7-[3,5-Dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl) phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic acid, 1-methylethylester. It has a molecular formula of C 26 H 35 F 3 O 6 and a molecular weight of 500.55 g/mol.
Brands: Travoprost
Travoprost (isomer Free)
travoprost (isomer free)
11 DESCRIPTION Travoprost is a synthetic prostaglandin F analog. Its chemical name is [1 R - [1α( Z ),2β(1 E ,3 R *),3α,5α]]-7-[3,5-Dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl) phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic acid, 1-methylethylester. It has a molecular formula of C 26 H 35 F 3 O 6 and a molecular weight of 500.55 g/mol.
Brands: Travoprost
Travoprost Intracameral
travoprost intracameral
11 DESCRIPTION iDose TR (travoprost intracameral implant) is a sterile intracameral implant containing 75 mcg of travoprost. The intracameral implant consists of a titanium implant reservoir with a membrane controlling the sustained release of travoprost. The sterile implant is pre-loaded in a sterile single-dose inserter to facilitate insertion directly through the trabecular meshwork of the anterior chamber angle into the sclera. Travoprost is a prostaglandin analog.
Brands: Idose Tr
Travoprost Ophthalmic
travoprost ophthalmic
11 DESCRIPTION Travoprost is a synthetic prostaglandin F analog. Its chemical name is [1R-[1α(Z),2β(1E,3R*),3α,5α]]-7-[3,5-Dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic acid, 1-methylethylester. It has a molecular formula of C 26 H 35 F 3 O 6 and a molecular weight of 500.55 g/mol. The chemical structure of travoprost is: Travoprost USP, is a clear, colorless, viscous oil that is very soluble in acetonitrile, methanol, octanol, and chloroform.
Brands: Travoprost Ophthalmic Solution
Travoprost Ophthalmic Solution
travoprost ophthalmic solution
11 DESCRIPTION Travoprost is a synthetic prostaglandin F analog. Its chemical name is [1 R -[1α( Z ),2β(1 E ,3 R *),3α,5α]]-7-[3,5-Dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl) phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic acid, 1-methylethylester. It has a molecular formula of C 26 H 35 F 3 O 6 and a molecular weight of 500.55 g/mol.
Brands: Travoprost Ophthalmic Solution
Travoprost Ophthalmic Solution Usp, 0.004%
travoprost ophthalmic solution usp, 0.004%
11 DESCRIPTION Travoprost is a synthetic prostaglandin F analogue. Its chemical name is [1R-[1α(Z),2β(1E,3R*),3α,5α]]-7-[3,5Dihydroxy-2-[3-hydroxy-4-[3(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5heptenoic acid, 1-methylethylester. It has a molecular formula of C 26 H 35 F 3 O 6 and a molecular weight of 500.55. The chemical structure of travoprost is: Travoprost is a clear, colorless and viscous oil that is very soluble in acetonitrile, methanol, octanol, and chloroform.
Brands: Travoprost Ophthalmic Solution Usp, 0.004% Travoprost
Medical Disclaimer
This drug database is for informational purposes only. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.